starting tirzepatide dose The standard 2.5 mg of may be too high for some people. Some clinicians use lower customized doses in sensitive patients to reduce nausea, fatigue and excessive appetite suppression Tirzepatide (Month 1) 2.5mg |

Additionally, it helps curb appetite, contributing to its weight loss effects

FDA Approval Timeline: From NDA to Market Launch NDA Submission: Q4 2026 Eli Lilly will compile efficacy data primarily from TRIUMPH-1, supportive data from TRIUMPH-4, the safety database across all trials, and manufacturing/labeling documentation

Return partly-used pens to your pharmacy for safe disposal

EJNMMI Res 12:20 Koirala P, Chen SPR, Boer JC, Khalil ZG, Deceneux C, Goodchild G, Lu L, Faruck MO, Shalash AO et al (2023) Polymeric nanoparticles as a self-adjuvanting peptide vaccine delivery system: the role of shape

Both TRIUMPH-2 and TRIUMPH-3 met their primary endpoints, expanding the clinical evidence for retatrutide in two of obesitys most significant comorbidities: type 2 diabetes and established cardiovascular disease